Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

NodeGuardian

2026-03-21 16:34:20

Abstract generation in progress

Levi & Korsinsky has initiated an investigation into Agios Pharmaceuticals, Inc. (AGIO) for potential violations of federal securities laws. This follows Agios’s announcement on November 19, 2025, concerning its RISE UP Phase 3 trial, which failed to meet a key secondary endpoint regarding pain crises and fatigue, causing a significant drop in its stock price. Investors who lost money on AGIO are encouraged to contact the law firm for more information.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.